Helix Biopharma Corp HBP:Toronto Stock Exchange

*Data is delayed | Exchange | CAD
Last | 05/03/24 EDT
0.205quote price arrow down-0.005 (-2.3809%)
Volume
509
52 week range
0.15 - 0.26
Loading...
  • Open0.205
  • Day High0.205
  • Day Low0.205
  • Prev Close0.21
  • 52 Week High0.26
  • 52 Week High Date10/11/23
  • 52 Week Low0.15
  • 52 Week Low Date10/19/23

Key Stats

  • Market Cap30.83M
  • Shares Out229.44M
  • 10 Day Average Volume26,297.6
  • Dividend-
  • Dividend Yield-
  • Beta-0.97
  • YTD % Change-2.38

KEY STATS

  • Open0.205
  • Day High0.205
  • Day Low0.205
  • Prev Close0.21
  • 52 Week High0.26
  • 52 Week High Date10/11/23
  • 52 Week Low0.15
  • 52 Week Low Date10/19/23
  • Market Cap30.83M
  • Shares Out229.44M
  • 10 Day Average Volume26,297.6
  • Dividend-
  • Dividend Yield-
  • Beta-0.97
  • YTD % Change-2.38

RATIOS/PROFITABILITY

  • EPS (TTM)-0.03
  • P/E (TTM)-7.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Helix Biopharma Corp

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Helix BioPharma Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is engaged in developing therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47. DOS47 is an oncology platform technology that offers a debilitation and destruction of cancer cells. DOS47 is designed to stimulate an increase in the Potential of Hydrogen (pH) of the microenvironment surrounding the cancerous cells, effectively reversing the...
Jacek Antas
Chief Executive Officer, Director
Hatem Kawar
Chief Financial Officer
Address
401 Bay Street,, Suite 2704,
PO Box 4
Toronto, ON
M5H 2Y4
Canada

Top Peers

SYMBOLLASTCHG%CHG
APS
MBX
EDSA
Edesa Biotech Inc
4.54-0.01-0.33%
ATE
AEZS
Aeterna Zentaris Inc
7.84-0.20-2.49%